Matako, Y.; Suttisingtong, K.; Boonsombat, J.; Sirirak, J.; Limpachayaporn, P. The Synthetic Pathways of a New 1,2,3-Triazole-Containing Sorafenib Analogue and Its Cytotoxicity towards Cancer Cell Lines. rmutsvrj 2021, 13, 244–258.

01 May 2021
0

Matako, Y.; Suttisingtong, K.; Boonsombat, J.; Sirirak, J.; Limpachayaporn, P. The Synthetic Pathways of a New 1,2,3-Triazole-Containing Sorafenib Analogue and Its Cytotoxicity towards Cancer Cell Lines. rmutsvrj 202113, 244–258.

Tags

Share this

Related Posts

Bridging the gap between clinicians and systems biologists: From network biology to translational biomedical research. Jinawath N, Bunbanjerdsuk S, Chayanupatkul M, Ngamphaiboon N, Asavapanumas N, Svasti J, Charoensawan V*. J Transl Med 2016;14(1):324.

Recent Posts